Hemophilia Center of Western PA

Pittsburgh, Pennsylvania 15213-4306

2 studies enrolling now · 12 studies all time

What they study most

Hemophilia A, Hemophilia A With Inhibitor, Hemophilia A Without Inhibitor, Hemophilia B, Postpartum Hemorrhage, Sickle Cell Disease, Von Willebrand Disease, Von Willebrand Disease (VWD), Von Willebrand Diseases

Studies at this site

• Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) — Recruiting now
• Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) — Recruiting now
• Research Study Investigating How Well NDec Works in People With Sickle Cell Disease — Completed
• Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial — Completed
• A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A — Completed
• The Hemophilia Inhibitor Prevention Trial — Stopped early
• The Hemophilia Inhibitor Eradication Trial — Stopped early
• A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A) — Completed
• Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease — Completed
• Phase I/IIa Study of FIXFc in Hemophilia B Patients — Completed
• IL-11 in Adults With Von Willebrand Disease Undergoing Surgery — Stopped early
• IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia — Completed